Loading clinical trials...
Loading clinical trials...
A Bioavailability and Food Effect Study of Venetoclax New Tablet Formulation 2.0 in Healthy Female Subjects
Conditions
Interventions
Venetoclax
Locations
2
United States
Acpru /Id# 272979
Grayslake, Illinois, United States
PPD Phase I Clinic /ID# 275754
Austin, Texas, United States
Start Date
December 19, 2024
Primary Completion Date
October 8, 2025
Completion Date
October 8, 2025
Last Updated
October 15, 2025
NCT07310264
NCT00090662
NCT06342713
NCT06223555
NCT07472361
NCT01266577
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions